← Back to all trials
Recruiting
NCT06446661
Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia
Sex: All
Ages: 15 Years – 39 Years
Healthy volunteers: No
Phase: NA
Enrollment: 38
Sponsor: University of Chicago
Location: University of Chicago Medicine Comprehensive Cancer Center Chicago Illinois
Summary
The purpose of this section is to learn how text message reminders might help with regularly taking chemotherapy medications for Adolescents and Adults with Acute Lymphoblastic leukemia (ALL).
Eligibility Criteria
Inclusion Criteria:
* Age of 15-39 years-old at the time of initial ALL diagnosis
* Diagnosed with ALL
* Currently receiving treatment with pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (e.g., CALGB 10403). Study participation begins with the start of maintenance, so enrollment occurs prior to the start of maintenance.
Exclusion Criteria:
* Patient or caregiver who would receive text message reminders does not have a cell phone that receives text messages
* Patient does not wish to participate
* Text messages will be crafted in the patient's preferred language for medical communication, so English fluency is not an enrollment requirement.
Source: ClinicalTrials.gov (NCT06446661). StuddyBuddy aggregates publicly available trial information.